Trial of Chinese Prescription on Ulcerative Colitis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00963287

Enrollment

200

Registered

2009-08-21

Start date

2009-08-31

Completion date

2011-08-31

Last updated

2016-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Keywords

alternative medicine, traditional Chinese medicine

Brief summary

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription on Ulcerative Colitis.

Interventions

DRUGbascial prescription plus or minus herbs depend on symptoms

Decoction ,two times a day

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of ulcerative colitis * Male of female patients between 18-65 years old * Written informed consent

Exclusion criteria

* Combine with malignant pathology on epithelial dysplasia of mucosa * Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease. * Pregnancy or breast feeding women, or unwilling to have contraception.

Design outcomes

Primary

Measure	Time frame
Histopathological examination,enteroscopy,blood test,symptoms ,pulse tracings,tongue demonstration	8 weeks

Secondary

Measure	Time frame
Indicates of liver and renal function	8 weeks

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026